Exfoliative dermatitis secondary to tobramycin sulfate.
We report a case of exfoliative dermatitis clearly linked to intravenous and intraperitoneal administration of tobramycin. Despite the complicated drug regimen with which the patient was treated, tobramycin was implicated by rechallenge with the drug once before its role was understood and again at an outside hospital.
Karp
S
S
Department of Medicine, Michael Reese Hospital, Chicago, Illinois.
Bakris
G
G
Cooney
A
A
Rubenstein
D
D
Hou
S H
SH
D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D010538:Peritonitis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D014031:Tobramycin / Q000008:administration & dosage / Q000009:adverse effects*
D014031:Tobramycin